15-Deoxy-Δ12,14-prostaglandin J2 Regulates Endogenous Cot MAPK Kinase Kinase 1 Activity Induced by Lipopolysaccharide
Authors
Discussion
Loading...
Member takes
Implication
Laboratory study examines how 15-deoxy-Δ12,14-prostaglandin J2 affects Cot activity in macrophages, highlighting its anti-inflammatory potential.
Key Points
- Investigate the regulatory effects of 15-deoxy-Δ12,14-prostaglandin J2 on Cot activity in response to lipopolysaccharide in macrophages.
- Measured Cot activity in RAW264 macrophages after stimulation with lipopolysaccharide (LPS).
- Evaluated the effects of Taxol and phorbol 12-myristate 13-acetate (PMA) on Cot activation.
- Assessed the inhibitory effects of 15-deoxy-Δ12,14-prostaglandin J2 and rosiglitazone on LPS-induced Cot activation.
- LPS increased endogenous Cot activity by 10-fold in RAW264 macrophages.
- 15-deoxy-Δ12,14-prostaglandin J2 effectively blocked LPS-induced Cot activation.
- PMA did not trigger Cot activation, and 15-deoxy-Δ12,14-prostaglandin J2 did not inhibit ERK1/ERK2 activation by PMA.
Cite This Study
Caivano et al. (2003) studied this question.